Profil
Michael Lytton served as Deputy Chairman-Supervisory Board at GPC Biotech AG, Chairman at Santhera Pharmaceuticals Holding AG, Chairman-Technology Group & Partner at Edwards Angell Palmer & Dodge LLP, Chairman at Medicine in Need Corp., Non-Executive Director at Acambis Plc, Director at Radius Health, Inc., Decision Biomarkers, Inc., Molecular Biometrics, Inc., Melinta Subsidiary Corp., Director-Executive Board at Alantos Pharmaceuticals AG, Director at Enanta Pharmaceuticals, Inc., OPKO Diagnostics LLC, First Light Diagnostics, Inc., Executive Vice President-Business Development at Biogen, Inc., General Partner at Oxford Bioscience Partners, General Counsel, EVP-Development & Strategy at Patheon, Inc., Partner at Wilmer Cutler Pickering Hale & Dorr LLP, EVP-Corporate & Business Development at Biogen Idec New Ventures, Inc., Partner at Edwards Wildman Palmer LLP, and EVP-Corporate Development & Strategy at Patheon NV.
He holds a graduate degree from Harvard University, an undergraduate degree from Princeton University, and a graduate degree from the London School of Hygiene & Tropical Medicine.
Anciens postes connus de Michael Lytton
| Sociétés | Poste | Fin |
|---|---|---|
| PATHEON N.V. | Corporate Officer/Principal | 05/12/2016 |
First Light Diagnostics, Inc.
First Light Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops automated diagnostic products for antibiotic-resistant infections | Directeur/Membre du Conseil | 05/12/2016 |
Medicine in Need Corp.
Medicine in Need Corp. Internet Software/ServicesTechnology Services Operates online medicine directory for a number of pharmaceutical drugs | Président | 05/12/2016 |
Alantos Pharmaceuticals AG
Alantos Pharmaceuticals AG BiotechnologyHealth Technology Develops and manufactures molecule pharmaceuticals for arthritic and metabolic diseases | Corporate Officer/Principal | 05/12/2016 |
| PATHEON, INC. | Conseiller Juridique Général | 03/06/2014 |
Formation de Michael Lytton
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations. | Finance |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines | Health Technology |
Patheon, Inc.
Patheon, Inc. Pharmaceuticals: MajorHealth Technology Provides drug development and manufacturing services | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Decision Biomarkers, Inc.
Decision Biomarkers, Inc. Miscellaneous Commercial ServicesCommercial Services Provides technology services | Commercial Services |
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops analytical methodologies for molecular diagnostic | Commercial Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Commercial Services |
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Alantos Pharmaceuticals AG
Alantos Pharmaceuticals AG BiotechnologyHealth Technology Develops and manufactures molecule pharmaceuticals for arthritic and metabolic diseases | Health Technology |
Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
London School of Hygiene & Tropical Medicine
London School of Hygiene & Tropical Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edwards Angell Palmer & Dodge LLP
Edwards Angell Palmer & Dodge LLP Miscellaneous Commercial ServicesCommercial Services Edwards Angell Palmer & Dodge manages separate portfolios consisting primarily of the stocks of US large-cap companies in the health technology, electronic technology, consumer non-durables and manufacturing sectors. The firm maintains a very low turnover rate | Commercial Services |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Medicine in Need Corp.
Medicine in Need Corp. Internet Software/ServicesTechnology Services Operates online medicine directory for a number of pharmaceutical drugs | Technology Services |
OPKO Diagnostics LLC
OPKO Diagnostics LLC Medical/Nursing ServicesHealth Services Provides health services | Health Services |
Edwards Wildman Palmer LLP
Edwards Wildman Palmer LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
First Light Diagnostics, Inc.
First Light Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops automated diagnostic products for antibiotic-resistant infections | Health Technology |
Patheon NV
Patheon NV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development and manufacturing services | Health Technology |
Banner Life Sciences LLC
Banner Life Sciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
















